United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - glyceryl trinitrate - transdermal patch - 15mg/24hour

Malta - English - Medicines Authority

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - glyceryl trinitrate - transdermal patch - glyceryl trinitrate 5 mg/24 h - cardiac therapy

Malta - English - Medicines Authority

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - nitroglycerin - transdermal patch - nitroglycerin 10 mg/24 h - cardiac therapy

United States - English - NLM (National Library of Medicine)

bausch health us, llc - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - nitroglycerin 9 mg - transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of transdermal nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute attack. nitroglycerin is contraindicated in patients who are allergic to it. allergy to the adhesives used in nitroglycerin patches has also been reported, and it similarly constitutes a contraindication to the use of this product. do not use minitran in patients who are taking phosphodiesterase inhibitors (such as sildenafil, tadalafil, or vardenafil) for erectile dysfunction or pulmonary arterial hypertension. concomitant use can cause severe drops in blood pressure. do not use minitran in patients who are taking the soluble guanylate cyclase stimulator riociguat. concomitant use can cause hypotension.

Canada - English - Health Canada

valeant canada lp / valeant canada s.e.c. - nitroglycerin - patch - 0.2mg - nitroglycerin 0.2mg - nitrates and nitrites

Canada - English - Health Canada

valeant canada lp / valeant canada s.e.c. - nitroglycerin - patch - 0.6mg - nitroglycerin 0.6mg - nitrates and nitrites

Canada - English - Health Canada

valeant canada lp / valeant canada s.e.c. - nitroglycerin - patch - 0.4mg - nitroglycerin 0.4mg - nitrates and nitrites

United States - English - NLM (National Library of Medicine)

graceway pharmaceuticals, llc - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - nitroglycerin 2.5 mg in 1 d - transdermal nitroglycerin is indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of transdermal nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute attack. allergic reactions to organic nitrates are extremely rare, but they do occur. nitroglycerin is contraindicated in patients who are allergic to it. allergy to the adhesives used in nitroglycerin patches has also been reported, and it similarly constitutes a contraindication to the use of this product.